Despite the availability of HPV vaccination and Pap test screening, nearly 13,000 women are diagnosed with cervical cancer in the United States each year.
Congress designated January as Cervical Health Awareness Month to raise awareness about the disease and the importance of vaccination and early detection.
In light of this awareness month, HemOnc Today compiled a list of five articles related to advances in cervical cancer detection and treatment, new data on the role of HPV positivity, and the persistent underuse of HPV vaccination and cervical cancer screening.
- The rate of women in the Upper Midwest who underwent cervical cancer screening in 2016 was lower than nationally reported rates, which researchers deemed “unacceptable.” Read more.
- A new epigenetic test for cervical cancer demonstrated 100% accuracy, predicting development of the disease as many as 5 years in advance. Read more.
- Women positive for HPV16 or HPV18 but who do not have any cellular abnormalities remain at an increased risk for cervical cancer and its precursor lesions. Read more.
- HPV vaccination rates among adolescents must increase substantially for the American Cancer Society to achieve its goal of 80% prevalence by 2026. Read more.
- Women with early-stage cervical cancer who underwent minimally invasive radical hysterectomy had higher rates of recurrence and worse survival outcomes than women who had open surgery. Read more.